Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
569 studies found for:    "Uveal diseases"
Show Display Options
Rank Status Study
1 Unknown  Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease
Conditions: Behcet Syndrome;   Uveal Disease
Intervention: Drug: Etanercept, Methotrexate, Prednisolone
2 Completed Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study
Conditions: Uveitis;   Cancer;   Infection;   Mortality;   Immunosuppression
Intervention:
3 Not yet recruiting Ozurdex® in Patients With Non-infectious Uveitis Affecting the Posterior Segment of the Eye
Condition: Non-infectious Uveitis
Intervention: Drug: dexamethasone intravitreal implant
4 Not yet recruiting ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study)
Condition: Uveitis
Intervention: Drug: ACTH gel
5 Not yet recruiting Randomized Trial Comparing Efficacy of Adalimumab, Anakinra and Tocilizumab in Non-infectious Refractory Uveitis
Conditions: Uveitis;   Biotherapy
Interventions: Drug: Anakinra;   Drug: Tocilizumab;   Drug: Adalimumab
6 Not yet recruiting HUMIRA® Long-term Treatment in Patients With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Condition: Uveitis
Intervention:
7 Recruiting Ustekinumab (STELARA ) for the Treatment of Active Sight-Threatening Uveitis
Condition: Uveitis
Intervention: Drug: Ustekinumab
8 Recruiting Measurement of Anterior Chamber Cell Grading Using Ocular Coherence Tomography
Condition: Uveitis
Interventions: Device: Optical Coherence Tomography (OCT);   Other: Eye Exam
9 Recruiting Microbiological Diagnosis of Infectious Uveitis to Pathogenic Fastidious Germs
Condition: Uveitis
Intervention: Other: Blood sampling
10 Recruiting Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious Uveitis
Conditions: Uveitis;   Non-Infectious Uveitis
Intervention: Drug: Adalimumab
11 Recruiting Uveitis/Intraocular Inflammatory Disease Biobank (iBank)
Condition: Uveitis
Intervention:
12 Not yet recruiting Factors Affecting Aqueous Humor Outflow Facility in Patients With Uveitis
Conditions: UVeitis;   Glaucoma
Intervention:
13 Suspended Treatment of the Bilateral Severe Uveitis by IVT of Regulator T-cells: Study of Tolerance of Dose
Condition: Uveitis
Intervention: Other: intravitreous administration of regulator T-cells
14 Recruiting Childhood Uveitis Initial Management and One-year Outcomes
Condition: Uveitis.
Intervention: Other: Surveillance card
15 Terminated Long-term Safety of Gevokizumab in the Treatment of Patients With Chronic Non-infectious Uveitis (EYEGUARD-X)
Condition: Chronic Uveitis
Intervention: Biological: Gevokizumab
16 Recruiting Genetics of Uveitis
Conditions: Uveitis;   Infectious Uveitis
Intervention:
17 Not yet recruiting Grading Scale of Vitreous Haze in Patients With Uveitis Using Ultrasonography
Condition: Uveitis
Intervention: Device: Ultrasonography B-scan
18 Terminated An Open-label, Rollover Study Providing Continued Dosing of Gevokizumab in Order to Assess Long-term Gevokizumab Safety Data
Condition: Uveitis
Intervention: Drug: Dose 2 gevokizumab
19 Recruiting Use of Simvastatin as a Steroid Sparing Agent for Uveitis Patients
Condition: Uveitis
Interventions: Drug: Simvastatin;   Drug: Placebo
20 Enrolling by invitation A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
Condition: Non-Infectious Uveitis of the Posterior Segment of the Eye
Intervention: Drug: DE-109

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.